What is naloxone and should everyone have access to it?

Two panels that advise the Food and Drug Administration are recommending that naloxone nasal spray be approved for over-the-counter sale for emergency treatment of opioid overdoses. The Joint Nonprescription Drugs Advisory Committee and the Anesthetic and Analgesic Drug Products Advisory Committee voted unanimously to approve the measure. The FDA will make a final decision on March 29 if naloxone will become a nonprescription drug.

Study shows 1 in 25 patients undergoing structural cardiac intervention suffered a major complication

Researchers at the University of Alabama at Birmingham Marnix E. Heersink School of Medicine published a study in the Journal of the American Society of Echocardiography showing that transesophageal echocardiography (TEE)-guided transcatheter structural cardiac intervention was associated with a major complication in 3.6% of patients.